Q4 FY2022 Revenue of $955.0 million vs. $894.3 million in Q4 last year, up 7% year-over-year (up 25% ex. revenue from ventilators) Earnings per share (EPS) of.
Q4 FY2022 Revenue of $955.0 million vs. $894.3 million in Q4 last year, up 7% year-over-year (up 25% ex. revenue from ventilators) Earnings per share (EPS) of.